Skip to main content
32 search results for:

Macular edema 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 14-07-2022 | Retinopathy | News | Article
    News in brief

    ‘Step therapy’ compromise preserves good outcomes in diabetic macular edema

    Starting people on bevacizumab and switching to aflibercept only when necessary keeps costs down without compromising treatment efficacy for people with diabetic macular edema, shows a randomized trial.

  2. 28-01-2022 | Retinopathy | News | Article

    Intravitreal faricimab shows potential for diabetic macular edema

    The dual Ang-2 and VEGF-A pathway inhibitor faricimab is noninferior to aflibercept for improving visual acuity in people with diabetic macular edema, and an individualized dosing strategy could help reduce treatment burden, suggest findings from the YOSEMITE and RHINE trials.

  3. 01-05-2019 | Retinopathy | News | Article

    No rush to treat diabetic macular edema with good visual acuity

    Research published in JAMA shows similar outcomes for patients with center-involved diabetic macular edema and good visual acuity over the first 2 years after diagnosis, regardless of whether they are managed with aflibercept, laser photocoagulation, or observation.

  4. 26-02-2018 | Macular edema | Figure | Image

    Management of diabetic macular edema

    Macmillan Publishers Limited, part of Springer Nature
  5. 26-02-2018 | Macular edema | Figure | Image

    Algorithm for management of refractory diabetic macular edema

    Springer International Publishing Switzerland
  6. 07-03-2018 | Retinopathy | News | Article
    News in brief

    Light mask ruled out for preventing early diabetic macular edema progression

    The CLEOPATRA trial results show that wearing a mask that emits blue–green light during sleep does not reduce the progression of non-central diabetic macular edema.

  7. 14-02-2017 | Macular edema | Review | Article

    Therapeutic options in refractory diabetic macular edema

    Diabetic macular oedema (DMO) results from alterations of several biochemical pathways in diabetic eyes.

  8. 25-02-2017 | Macular edema | Article

    Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema

    Bahrami B et al. Graefes Arch Clin Exp Ophthalmol 2017; 255: 1133–1140. doi: 10.1007/s00417-017-3624-y

  9. 31-05-2017 | Macular edema | Review | Article

    Action on diabetic macular edema: Achieving optimal patient management in treating visual impairment due to diabetic eye disease

    Eye 2017; 31: S1–S20. doi: 10.1038/eye.2017.53

  10. 01-12-2015 | Retinopathy | Review | Article

    Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss

    Lee R et al. Eye and Vis 2015; 2: 17. doi: 10.1186/s40662-015-0026-2

  11. 28-04-2017 | Retinopathy | Article

    Influence of baseline diabetic retinopathy status on initial anatomical response of intravitreal ranibizumab therapy for diabetic macular oedema

    Eye 2017; 31: 1358–1364. doi: 10.1038/eye.2017.69

  12. 14-01-2022 | Diabetic foot ulcers | News | Article

    Intensive glycemic control may prevent diabetic foot ulcers

    Sustained estimated glomerular filtration rate below 60 mL/min per 1.73 m 2 (HR=2.63), albuminuria (HR=2.23), and macular edema (HR=3.13) were associated with a significantly increased risk for amputation.

  13. 04-07-2017 | Complications | News | Article

    June Cochrane review round-up

    Here we provide an overview of the seven Cochrane reviews published in June that covered topics relating to diabetes, including glycemic control for prevention of renal failure, phototherapy for foot ulcers, and anti-vascular endothelial growth factor treatment for diabetic macular edema.

  14. 29-10-2021 | Retinopathy | News | Article
    News in brief

    Sight-threatening retinopathy an early risk for youth-onset type 2 diabetes

    Also, 3.8% had clinically significant macular edema.

  15. 11-05-2017 | Retinopathy | News | Article

    Severe diabetic retinopathy linked to increased cardiovascular risk

    Individuals with diabetic macular edema or proliferative diabetic retinopathy are more likely to develop and die from cardiovascular disease than those without either condition, results of a systematic review and meta-analysis show.

  16. 22-08-2017 | Retinopathy | Editorial | Article

    Antivascular endothelial growth factor treatment for proliferative diabetic retinopathy: Perspective on the CLARITY study

    Since DME could be a bias for measuring visual acuity results, eyes with macular edema were excluded as opposed to the Protocol S study.

  17. 21-03-2017 | Retinopathy | Review | Article

    A review of ranibizumab for the treatment of diabetic retinopathy

    Introduction: Laser photocoagulation has been the standard treatment for diabetic macular edema (DME) and proliferative diabetic retinopathy (PDR)

  18. 01-10-2016 | Retinopathy | Review | Article

    Fenofibrate and diabetic retinopathy

    Knickelbein JE, Abbott AB, Chew EY. Curr Diab Rep 2016; 16: 90. doi: 10.1007/s11892-016-0786-7

  19. 16-12-2020 | Aflibercept | News | Article

    Similar visual outcomes may be achieved with aflibercept vs vitrectomy

    In contrast, the aflibercept group experienced less frequent center-involved diabetic macular edema and avoided vitrectomy in two-thirds of participants.”

  20. 12-05-2017 | Aflibercept | News | Article

    Aflibercept has edge over laser retinopathy treatment in CLARITY trial

    But they observe that it could also be due to differences in the trials’ patient populations; the ranibizumab trial recruited only untreated patients with high-risk proliferative diabetic retinopathy, and included those with macular edema, whereas only 23% of CLARITY participants were high risk, 47% had previously undergone PRP, and none had macular edema.

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.